NEUP
Neuphoria Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.54
-0.19 ▼ -4.02%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$4.54
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -23.89 | Insider Own | 9.09% | Shs Outstand | - | Perf Week | 5.09% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | 373.98% | Shs Float | 0.00B | Perf Month | 13.22% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | - | Inst Own | 85.41% | Short Float | 0.84% | Perf Quarter | 7.84% |
| Income | 0.01B | P/S | 0.55 | EPS this Y | - | Inst Trans | 39.1% | Short Ratio | 0.29 | Perf Half Y | -67.55% |
| Sales | 0.02B | P/B | 0.82 | EPS next 5Y | - | ROA | - | Short Interest | 0.01M | Perf YTD | 17.01% |
| Book/sh | 5.52 | P/C | 0.38 | EPS past 3/5Y | -17.62% -20.01% | ROE | - | 52W High | -78.79% ($21.40) | Perf Year | -6.2% |
| Cash/sh | 11.84 | P/FCF | 16.74 | Sales past 3/5Y | 334.17% 246.61% | ROIC | 19.62% | 52W Low | 24.55% ($3.64) | Perf 3Y | -87.72% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -15957.73% | Gross Margin | - | Volatility(W/M) | 6.41% 5.61% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | -0.87 | Sales Y/Y TTM | - | Oper. Margin | -4.93% | ATR (14) | 0.24 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 9.04 | EPS Q/Q | -22040% | Profit Margin | 37.2% | RSI (14) | 55.8 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.04 | Sales Q/Q | - | SMA20 | 3.15% ($4.4) | Beta | 0.43 | Target Price | $7 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/02/26 | SMA50 | 8.52% ($4.18) | Rel Volume | 2.4 | Prev Close | $4.73 |
| Employees | 8 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -232.4% - | SMA200 | -35.65% ($7.06) | Avg Volume(3M) | 0.05M | Price | $4.54 |
| IPO | 2021/12/16 | Option/Short | No/Yes | Trades | 439 | Volume | 117,207 | Change | -4.02% |
뉴스 로딩 중...